Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-000964
Filing Date
2025-03-18
Accepted
2025-03-18 20:51:28
Documents
1
Period of Report
2025-03-14

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5682
  Complete submission text file 0000905148-25-000964.txt   7238
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 9713 KEY WEST AVENUE SUITE 400 ROCKVILLE MD 20850
Business Address
Soleymannezhad Ali (Reporting) CIK: 0002037336 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40674 | Film No.: 25750570